Moderna (NasdaqGS:MRNA) reported positive Phase 3 clinical data for its investigational influenza vaccine mRNA-1010 and RSV ...

Investors may be asking whether Moderna's current share price reflects its underlying worth, or if the market is mispricing ...

European Medicines Agency approves Moderna's mRNA flu vaccine with strong efficacy in older adults. US FDA initially declines ...

This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per GlobalData.

During the pharma earnings season, which begins on Tuesday, Novo Nordisk will report the first revenue numbers from an oral ...

But the gains for many value stocks are now at risk, with the escalating conflict in Iran roiling the stock market, sending oil prices ratcheting higher and sparking fears of an economic downturn. The ...

Chief among its criticisms is Novavax's failure to build sales of its protein-based COVID-19 vaccine Nuvaxovid/Covovax, a ...

"Your tenure has overseen a DESTRUCTION of shareholder value—a direct result of chronic operational shortcomings and failures ...

The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Oil prices have surged 70% despite record U.S. output. Here’s what happens when global supply routes reopen—and which energy ...

On the heels of a comprehensive review, BioNTech has decided “to close its planned Singapore site by the end of February 2027 ...